Aktien Sensor

Medtronic PLC’s stock price target has been raised by analysts, driven by the company’s turnaround potential and growth catalysts in its cardiac ablation business.

Boston Scientific Corp’s stock value has surged over 145% in the past three years, with analysts recommending investment in the company due to its strong performance and potential for future growth.

Abbott Laboratories has reported continued growth, with a moderate increase in its stock price and a substantial market capitalization, driven by its focus on health care products and services.

Sonova Holding AG’s stock price has seen a moderate 2.5% increase, but experts caution against reading too much into the trend due to the volatile market.

Sigma Healthcare Ltd has reported strong revenue growth in Q2 2025, with a cautiously optimistic market sentiment and potential for long-term expansion in the evolving pharmaceutical industry.

RBC Capital has raised its price target for Universal Health Services to $206, citing the company’s continued growth trajectory and strong position in the healthcare industry.

Elevance Health Inc. faces a setback in its lawsuit against the US government over Medicare star ratings, but the company has also expanded its food as medicine support to community health centers.

Insulet’s stock price has stagnated, with a high price-to-earnings ratio and premium valuation, raising concerns about the company’s ability to deliver on its promises.

Veeva Systems has formed a long-term partnership with IQVIA to enhance clinical and commercial efficiency, effectiveness, and decision-making capabilities for healthcare organizations.

GE Healthcare Technologies has revised its annual earnings forecast, causing investors and analysts to reassess the company’s financial prospects amidst market fluctuations and uncertain future prospects.